Stem Cells, Inflammation and Allergy

Overview

Journal Allergy Asthma Clin Immunol

Specialty Allergy & Immunology

Date 2010 Jan 13

PMID 20066174

Citations 15

Authors

Marie-Renee Blanchet

Kelly M McNagny

Affiliations

Soon will be listed here.

Abstract

Recently, many studies have suggested a potential role for early hematopoietic progenitor cell and hematopoietic stem cell (HSC) recruitment and differentiation in the development of allergy and inflammation. This is based largely on evidence that stem cells or CD34+ progenitor cells are recruited to the site of inflammation in allergic diseases, likely through many of the same adhesion and chemokine receptors used for stem cell homing to the bone marrow (PSGL-1, CXCL12, alpha4-beta1 integrin, CD44, etc). Once at the site of inflammation, it has been suggested that stem cells could participate in the perpetuation of inflammation by maturing, locally, into inflammatory cells in response to the growth factors released in situ. Here we provide a brief review of the evidence to suggest that hematopoietic stem and progenitor cells (versus mature hematopoietic lineages) are, indeed, recruited to the site of allergic inflammation. We also discuss the molecules that likely play a role in this process, and highlight a number of our novel observations on a specific role for the stem cell antigen CD34 in this process.

Citing Articles

Inflammation-Associated Stem Cells in Gastrointestinal Cancers: Their Utility as Prognostic Biomarkers and Therapeutic Targets.

Kumari B, Tiwari A, Meena S, Ahirwar D Cancers (Basel). 2024; 16(18).

PMID: 39335106 PMC: 11429849. DOI: 10.3390/cancers16183134.

Recent advances of eosinophils and its correlated diseases.

Tao Z, Zhu H, Zhang J, Huang Z, Xiang Z, Hong T Front Public Health. 2022; 10:954721.

PMID: 35958837 PMC: 9357997. DOI: 10.3389/fpubh.2022.954721.

Redistribution, homing and organ-invasion of neoplastic stem cells in myeloid neoplasms.

Valent P, Sadovnik I, Eisenwort G, Herrmann H, Bauer K, Mueller N Semin Cancer Biol. 2019; 60:191-201.

PMID: 31408723 PMC: 7115853. DOI: 10.1016/j.semcancer.2019.07.025.

Inflammation Shapes Stem Cells and Stemness during Infection and Beyond.

Michael S, Achilleos C, Panayiotou T, Strati K Front Cell Dev Biol. 2016; 4:118.

PMID: 27853732 PMC: 5089974. DOI: 10.3389/fcell.2016.00118.

Alleviation of skin inflammation after Lin(-) cell transplantation correlates with their differentiation into myeloid-derived suppressor cells.

Ryu S, Ju J, Kim W, Kim M, Hee Oh K, Lee D Sci Rep. 2015; 5:14663.

PMID: 26441031 PMC: 4594128. DOI: 10.1038/srep14663.

References

Camp R, Scheynius A, Johansson C, Pure E . CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J Exp Med. 1993; 178(2):497-507. PMC: 2191099. DOI: 10.1084/jem.178.2.497. View

Levesque J, Hendy J, Takamatsu Y, Simmons P, Bendall L . Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest. 2003; 111(2):187-96. PMC: 151860. DOI: 10.1172/JCI15994. View

Allakhverdi Z, Comeau M, Smith D, Toy D, Endam L, Desrosiers M . CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation. J Allergy Clin Immunol. 2008; 123(2):472-8. DOI: 10.1016/j.jaci.2008.10.022. View

Sehmi R, Dorman S, Baatjes A, Watson R, Foley R, Ying S . Allergen-induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34+ cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammation. Immunology. 2003; 109(4):536-46. PMC: 1782995. DOI: 10.1046/j.1365-2567.2003.01686.x. View

Williams D, Rios M, Stephens C, Patel V . Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature. 1991; 352(6334):438-41. DOI: 10.1038/352438a0. View

Fukuda S, Bian H, King A, Pelus L . The chemokine GRObeta mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment. Blood. 2007; 110(3):860-9. PMC: 1924764. DOI: 10.1182/blood-2006-06-031401. View

Dorman S, Efthimiadis A, Babirad I, Watson R, Denburg J, Hargreave F . Sputum CD34+IL-5Ralpha+ cells increase after allergen: evidence for in situ eosinophilopoiesis. Am J Respir Crit Care Med. 2003; 169(5):573-7. DOI: 10.1164/rccm.200307-1004OC. View

Katayama Y, Hidalgo A, Furie B, Vestweber D, Furie B, Frenette P . PSGL-1 participates in E-selectin-mediated progenitor homing to bone marrow: evidence for cooperation between E-selectin ligands and alpha4 integrin. Blood. 2003; 102(6):2060-7. DOI: 10.1182/blood-2003-04-1212. View

Witte O . Steel locus defines new multipotent growth factor. Cell. 1990; 63(1):5-6. DOI: 10.1016/0092-8674(90)90280-r. View

10.

Erdag G, Qureshi H, Patterson J, Wick M . CD34-positive dendritic cells disappear from scars but are increased in pericicatricial tissue. J Cutan Pathol. 2008; 35(8):752-6. DOI: 10.1111/j.1600-0560.2007.00895.x. View

11.

van der Strate B, Popa E, Schipper M, Brouwer L, Hendriks M, Harmsen M . Circulating human CD34+ progenitor cells modulate neovascularization and inflammation in a nude mouse model. J Mol Cell Cardiol. 2007; 42(6):1086-97. DOI: 10.1016/j.yjmcc.2007.03.907. View

12.

Stirling R, van Rensen E, Barnes P, Chung K . Interleukin-5 induces CD34(+) eosinophil progenitor mobilization and eosinophil CCR3 expression in asthma. Am J Respir Crit Care Med. 2001; 164(8 Pt 1):1403-9. DOI: 10.1164/ajrccm.164.8.2010002. View

13.

Li J, Saito H, Crawford L, Inman M, Cyr M, Denburg J . Haemopoietic mechanisms in murine allergic upper and lower airway inflammation. Immunology. 2005; 114(3):386-96. PMC: 1782093. DOI: 10.1111/j.1365-2567.2005.02109.x. View

14.

Radinger M, Johansson A, Sitkauskiene B, Sjostrand M, Lotvall J . Eotaxin-2 regulates newly produced and CD34 airway eosinophils after allergen exposure. J Allergy Clin Immunol. 2004; 113(6):1109-16. DOI: 10.1016/j.jaci.2004.03.022. View

15.

Avigdor A, Goichberg P, Shivtiel S, Dar A, Peled A, Samira S . CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood. 2004; 103(8):2981-9. DOI: 10.1182/blood-2003-10-3611. View

16.

Nielsen J, McNagny K . Influence of host irradiation on long-term engraftment by CD34-deficient hematopoietic stem cells. Blood. 2007; 110(3):1076-7. DOI: 10.1182/blood-2006-11-059394. View

17.

Christensen J, Wright D, Wagers A, Weissman I . Circulation and chemotaxis of fetal hematopoietic stem cells. PLoS Biol. 2004; 2(3):E75. PMC: 368169. DOI: 10.1371/journal.pbio.0020075. View

18.

Massberg S, Schaerli P, Knezevic-Maramica I, Kollnberger M, Tubo N, Moseman E . Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell. 2007; 131(5):994-1008. PMC: 2330270. DOI: 10.1016/j.cell.2007.09.047. View

19.

Ponte A, Marais E, Gallay N, Langonne A, Delorme B, Herault O . The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells. 2007; 25(7):1737-45. DOI: 10.1634/stemcells.2007-0054. View

20.

Drew E, Merkens H, Chelliah S, Doyonnas R, McNagny K . CD34 is a specific marker of mature murine mast cells. Exp Hematol. 2002; 30(10):1211-8. DOI: 10.1016/s0301-472x(02)00890-1. View